16
CONCLUSIONS : These results indicate that even though OCT does not completely prevent the occurrence of hypercalcemia in experimental dogs with renal insufficiency , it may be of use in the management of secondary hyperparathyroidism because it does not induce low bone turnover and , therefore , does not increase the risk of adynamic bone disease .
 Chemical: OCT; Disease: hypercalcemia; Disease: renal insufficiency; Disease: secondary hyperparathyroidism; Disease: low bone turnover; Disease: adynamic bone disease
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: OCT; Disease: hypercalcemia; Disease: renal insufficiency; Disease: secondary hyperparathyroidism; Disease: low bone turnover; Disease: adynamic bone disease